Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease.

MLA

Sheehan, Kate, et al. “Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease.” The Protein Journal, vol. 44, no. 1, Feb. 2025, pp. 1–20. EBSCOhost, https://doi.org/10.1007/s10930-024-10237-6.

APA

Sheehan, K., Jeon, H., Corr, S. C., Hayes, J. M., & Mok, K. H. (2025). Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease. The Protein Journal, 44(1), 1–20. https://doi.org/10.1007/s10930-024-10237-6

Chicago

Sheehan, Kate, Hyesoo Jeon, Sinéad C Corr, Jerrard M Hayes, and K H Mok. 2025. “Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease.” The Protein Journal 44 (1): 1–20. doi:10.1007/s10930-024-10237-6.